Study to Investigate the Safety, Tolerability and Pharmacokinetics of AD 452 [(+)-Mefloquine] Compared With Racemic Mefloquine
This study has been completed.
Sponsor:
Treague Ltd
Collaborator:
Medicines for Malaria Venture
Information provided by:
Treague Ltd
ClinicalTrials.gov Identifier:
NCT00931697
First received: June 29, 2009
Last updated: July 30, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2009 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |